COVID-19 Vaccine Acceptance in Padang City, West Sumatra, Indonesia

Author:

Permatasari Dita,Sari Yelly Oktavia,Ranofan Rifo,Juwita Dian Ayu

Abstract

Background: Indonesia started the COVID-19 vaccination program in January 2021. West Sumatra, Indonesia, as one of the epicentres of the spread of COVID-19, has also begun the vaccination program. However, the Government has conducted no vaccine acceptance survey in this area as done in several other Indonesia regions. Aim: This study aims to see an overview of the acceptance of COVID-19 vaccination in West Sumatra, Indonesia. Methods: A descriptive research with a survey method using a questionnaire instrument given directly to the people of Padang, West Sumatra, Indonesia. The total respondents in this study amounted to 390 people based on inclusion criteria, with the method of taking accidental sampling. Results: This study showed that 38.2% of respondents were willing to be vaccinated, 27.9% refused to be vaccinated, and 33.8% had not decided to accept or reject the vaccine. Most respondents refused the vaccine with fear of side effects 42.9% and were concerned about vaccine safety 33.9%. More than half of the respondents (51.0%) wanted to vaccinate at public health centre. As many as 85.4% of respondents wanted to get more information about the COVID-19 vaccine being developed. Online platforms, print and electronic media are sources of information with about 40.5%, followed by face-to-face communication with 36.0% and social media with 23.5%. Conclusion: The people of Padang who stated that they were willing to undergo the COVID-19 vaccine program had not yet reached half of the number of respondents studied. However, this number has the opportunity to increase based on the enthusiastic trend of people who want to get more information about the COVID-19 vaccine. Providing correct and precise information should encourage the general public to participate in vaccination.

Publisher

Scientific Foundation SPIROSKI

Subject

General Medicine

Reference18 articles.

1. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. https://doi.org/10.1016/j.jaut.2020.102433 PMid:32113704

2. World Health Organizaton. Naming the Coronavirus Disease (COVID-19) and the Virus that Causes it. Geneva: World Health Organization; 2020.

3. World Health Organization. Coronavirus disease (COVID-19) Technical Guidance: The Unity Studies: Early Investigation Protocols. Geneva: World Health Organization; 2020.

4. Husada D. Vaksin SARS-CoV-2: Tinjauan kepustakaan. J Indones Med Assoc. 2020;70(10):228-42.

5. Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86(2):140-6. https://doi.org/10.2471/BLT.07.040089 PMid:18297169

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3